OBJECTIVE: Determine whether daily bathing with chlorhexidine-based soap decreased methicillin-resistant Staphylococcus aureus (MRSA) transmission and intensive care unit (ICU)-acquired S. aureus infection among ICU patients. DESIGN: Prospective pre-post-intervention study with control unit. SETTING: A 1,250-bed tertiary care teaching hospital. PATIENTS: Medical and surgical ICU patients. METHODS: Active surveillance for MRSA colonization was performed in both ICUs. In June 2005, a chlorhexidine bathing protocol was implemented in the surgical ICU. Changes in S. aureus transmission and infection rate before and after implementation were analyzed using time-series methodology. RESULTS: The intervention unit had a 20.68% decrease in MRSA acquisition after institution of the bathing protocol (12.64 cases per 1,000 patient-days at risk before the intervention vs 10.03 cases per 1,000 patient-days at risk after the intervention; β, -2.62 [95% confidence interval (CI), -5.19 to -0.04]; P = .046). There was no significant change in MRSA acquisition in the control ICU during the study period (10.97 cases per 1,000 patient-days at risk before June 2005 vs 11.33 cases per 1,000 patient-days at risk after June 2005; β, -11.10 [95% CI, -37.40 to 15.19]; P = .40). There was a 20.77% decrease in all S. aureus (including MRSA) acquisition in the intervention ICU from 2002 through 2007 (19.73 cases per 1,000 patient-days at risk before the intervention to 15.63 cases per 1,000 patient-days at risk after the intervention [95% CI, -7.25 to -0.95]; P = .012)]. The incidence of ICU-acquired MRSA infections decreased by 41.37% in the intervention ICU (1.96 infections per 1,000 patient-days at risk before the intervention vs 1.15 infections per 1,000 patient-days at risk after the intervention; P = .001). CONCLUSIONS: Institution of daily chlorhexidine bathing in an ICU resulted in a decrease in the transmission of S. aureus, including MRSA. These data support the use of routine daily chlorhexidine baths to decrease rates of S. aureus transmission and infection.
OBJECTIVE: Determine whether daily bathing with chlorhexidine-based soap decreased methicillin-resistant Staphylococcus aureus (MRSA) transmission and intensive care unit (ICU)-acquired S. aureus infection among ICU patients. DESIGN: Prospective pre-post-intervention study with control unit. SETTING: A 1,250-bed tertiary care teaching hospital. PATIENTS: Medical and surgical ICU patients. METHODS: Active surveillance for MRSA colonization was performed in both ICUs. In June 2005, a chlorhexidine bathing protocol was implemented in the surgical ICU. Changes in S. aureus transmission and infection rate before and after implementation were analyzed using time-series methodology. RESULTS: The intervention unit had a 20.68% decrease in MRSA acquisition after institution of the bathing protocol (12.64 cases per 1,000 patient-days at risk before the intervention vs 10.03 cases per 1,000 patient-days at risk after the intervention; β, -2.62 [95% confidence interval (CI), -5.19 to -0.04]; P = .046). There was no significant change in MRSA acquisition in the control ICU during the study period (10.97 cases per 1,000 patient-days at risk before June 2005 vs 11.33 cases per 1,000 patient-days at risk after June 2005; β, -11.10 [95% CI, -37.40 to 15.19]; P = .40). There was a 20.77% decrease in all S. aureus (including MRSA) acquisition in the intervention ICU from 2002 through 2007 (19.73 cases per 1,000 patient-days at risk before the intervention to 15.63 cases per 1,000 patient-days at risk after the intervention [95% CI, -7.25 to -0.95]; P = .012)]. The incidence of ICU-acquired MRSA infections decreased by 41.37% in the intervention ICU (1.96 infections per 1,000 patient-days at risk before the intervention vs 1.15 infections per 1,000 patient-days at risk after the intervention; P = .001). CONCLUSIONS: Institution of daily chlorhexidine bathing in an ICU resulted in a decrease in the transmission of S. aureus, including MRSA. These data support the use of routine daily chlorhexidine baths to decrease rates of S. aureus transmission and infection.
Authors: Ian M Gould; Fiona M MacKenzie; Graeme MacLennan; Diane Pacitti; Emma J Watson; David W Noble Journal: Int J Antimicrob Agents Date: 2007-03-06 Impact factor: 5.283
Authors: David K Warren; Rebecca M Guth; Craig M Coopersmith; Liana R Merz; Jeanne E Zack; Victoria J Fraser Journal: Infect Control Hosp Epidemiol Date: 2006-08-31 Impact factor: 3.254
Authors: Glenn Ridenour; Russell Lampen; Jeff Federspiel; Steve Kritchevsky; Edward Wong; Michael Climo Journal: Infect Control Hosp Epidemiol Date: 2007-08-01 Impact factor: 3.254
Authors: Susan C Bleasdale; William E Trick; Ines M Gonzalez; Rosie D Lyles; Mary K Hayden; Robert A Weinstein Journal: Arch Intern Med Date: 2007-10-22
Authors: Kyle J Popovich; Bala Hota; Robert Hayes; Robert A Weinstein; Mary K Hayden Journal: Infect Control Hosp Epidemiol Date: 2009-10 Impact factor: 3.254
Authors: Michael W Climo; Kent A Sepkowitz; Gianna Zuccotti; Victoria J Fraser; David K Warren; Trish M Perl; Kathleen Speck; John A Jernigan; Jaime R Robles; Edward S Wong Journal: Crit Care Med Date: 2009-06 Impact factor: 7.598
Authors: Susan S Huang; Edward Septimus; Ken Kleinman; Julia Moody; Jason Hickok; Taliser R Avery; Julie Lankiewicz; Adrijana Gombosev; Leah Terpstra; Fallon Hartford; Mary K Hayden; John A Jernigan; Robert A Weinstein; Victoria J Fraser; Katherine Haffenreffer; Eric Cui; Rebecca E Kaganov; Karen Lolans; Jonathan B Perlin; Richard Platt Journal: N Engl J Med Date: 2013-05-29 Impact factor: 91.245
Authors: C A Burnham; Patrick G Hogan; Meghan A Wallace; Elena Deych; William Shannon; David K Warren; Stephanie A Fritz Journal: Antimicrob Agents Chemother Date: 2016-11-21 Impact factor: 5.191
Authors: Arthur W Baker; Kristen V Dicks; Michael J Durkin; David J Weber; Sarah S Lewis; Rebekah W Moehring; Luke F Chen; Daniel J Sexton; Deverick J Anderson Journal: Infect Control Hosp Epidemiol Date: 2016-02-11 Impact factor: 3.254
Authors: Kristen V Dicks; Eric Lofgren; Sarah S Lewis; Rebekah W Moehring; Daniel J Sexton; Deverick J Anderson Journal: Infect Control Hosp Epidemiol Date: 2016-02-10 Impact factor: 3.254
Authors: Michael J Noto; Henry J Domenico; Daniel W Byrne; Tom Talbot; Todd W Rice; Gordon R Bernard; Arthur P Wheeler Journal: JAMA Date: 2015-01-27 Impact factor: 56.272
Authors: David K Warren; Martin Prager; Satish Munigala; Meghan A Wallace; Colleen R Kennedy; Kerry M Bommarito; John E Mazuski; Carey-Ann D Burnham Journal: Infect Control Hosp Epidemiol Date: 2016-02-02 Impact factor: 3.254